A teratogenic agent or teratogen can disturb the development of an embryo or a fetus. Fumonisin B 1 (FB 1 ), produced by Fusarium verticillioides and F. proliferatum, is among the most commonly seen mycotoxins and contaminants from stale maize and other farm products. It may cause physical or functional defects in embryos or fetuses, if the pregnant animal is exposed to mycotoxin FB 1 . Due to its high similarity in chemical structure with lipid sphinganine (Sa) and sphingosine (So), the primary component of sphingolipids, FB 1 plays a role in competitively inhibiting Sa and So, which are key enzymes in de novo ceramide synthase in the sphingolipid biosynthetic pathway. Therefore, it causes growth retardation and developmental abnormalities to the embryos of hamsters, rats, mice, and chickens. Moreover, maternal FB 1 toxicity can be passed onto the embryo or fetus, leading to mortality. FB 1 also disrupts folate metabolism via the high-affinity folate transporter that can then result in folate insufficiency. The deficiencies are closely linked to incidences of neural tube defects (NTDs) in mice or humans. The purpose of this review is to understand the toxicity and mechanisms of mycotoxin FB 1 on the development of embryos or fetuses.
General Features of Fumonisin B 1
Mycotoxin Fumonisins (FBs) are fungal secondary metabolites produced by Fusarium verticillioides and F. proliferatum. They are water soluble and contain two propane-1, 2, 3-tricarboxylic acid side chains, esterified to an aminopolyol backbone. Eighteen different related types have been identified and isolated [1, 2] . Fumonisin B 1 (FB 1 ) is clearly the most abundant analogue and the most prevalent mycotoxin contamination found in stale corn [3] [4] [5] [6] [7] [8] [9] . FB 1 contamination occurs in maize kernels and biosynthesis of FB 1 within the environment of the fungus-colonized kernel can be affected by the kernel composition. FB 1 production is at least five times higher in de-germed maize kernels than in germ tissue [10] . FB 1 biosynthesis varies with the
Toxicokinetic of FB 1
Mycotoxin FB 1 is difficult to absorb and can be rapidly excreted (urinary and biliary) in most species [38] . In rats, FB 1 can be excreted with feces (80%) and urine (3%), 96 h after intragastric administration of radiolabeled [ 14 C] FB 1 . However, low but consistent FB 1 levels can still be detected in the liver, kidneys, and blood [39] . Although the liver and kidneys are two major target organs retaining most of the absorbed toxins, FB 1 is also found in serum and other tissues in pigs, after oral administration [40, 41] .
Intestinal absorption of FB 1 and its biliary excretion are involved in the potential interactions between FB 1 and cholesterol [42] . Through interactions with cholesterol and bile salts, such as sodium taurocholate, dietary FB 1 could be incorporated into mixed micelles. Transfer of FB 1 to micelles facilitates its intestinal absorption [42] . A few studies have looked at the transfer of FB 1 from intestine to uterus or eggs. Previous studies in mammalian species suggested that FB 1 could cross the placenta when the pregnant mouse was exposed to FB 1 , during the early gestation period (embryonic day 7.5-8.5, E7.5-8.5) [43] . In the early gestation stage, the placenta is not yet well-formed, which potentially leaves the embryos vulnerable to teratogenic insults. However, when pregnant rats were exposed to FB 1 at later gestation period (E15), embryo development was not affected by the toxins, suggesting that the fully developed placenta might provide a protective barrier against a mycotoxin attack [44] . Nevertheless, no evidence has shown such FB 1 -placenta or FB 1 -egg transportation in humans and in avian species.
The FB 1 molecule includes a long chain aminopentol backbone (AP 1 ) with two ester-linked tricarballylic acids (TCA), in which AP 1 originates from the hydrolysis of the tricarballylic acid side chains, at carbons 14 and 15; it is then replaced by the hydroxyl groups [45] . Recent studies have demonstrated that swine cecal microbiota can metabolize FB 1 to partially hydrolysed FB 1 (PHFB 1 ) and a small amount of AP 1 [46] . In weaning piglets, the presence of PHB 1 and AP 1 is found in tissues with mostly unmetabolized FB 1 [47] .
Based on the intraperitoneal or intravenous dosing, the kinetics of FB 1 elimination is consistent with the one or two-compartment model. Depending on animal species, the initial elimination of FB 1 is rapid with a half-life of approximately 10 to 116 min, among different animals [48] [49] [50] [51] [52] [53] . In weaning piglets, however, FB 1 , PHB 1 , and AP 1 were detected in animal tissues, during a ten-day long elimination period [47] .
Mechanisms through Which the FB 1 Exerts Its Developmental Toxicity
Teratogens are known to interfere with embryonic or fetal development and cause congenital malformations (birth defects). Potential teratogens include radiation, maternal infections, chemicals and drugs, etc. [54] . In the case of corn contaminated with FB 1 , physical or functional defects in human and animal embryos or fetuses are possible when pregnant mothers are exposed. Therefore, FB 1 has also been proven to be among those potential teratogens during embryonic development.
The best-known mechanism of action for FB 1 is closely associated with sphingolipid metabolisms. Due to the similarity of its chemical structure ( Figure 1 ) with Sphinganine (Sa) and sphingosine (So) [1] [2] [3] 55] , FB 1 can interfere with the metabolism of Sa and So, the primary components of sphingolipids. Sphingolipids are widely distributed compounds and are often part of biomembranes. They regulate critical cell functions, such as cell proliferation, differentiation, and apoptosis [56, 57] . Therefore, during exposure, FB 1 serves as a competitive inhibitor for the Sa and So key enzymes in the de novo synthesis of ceramide, complicating the sphingolipid biosynthesis pathway (Figure 2 ) [58] [59] [60] . Inhibition of the ceramide synthase leads to a rapid increase of sphinganine, reduced sphingosine, elevated Sa/So, accumulations of the 1-phosphate metabolites of Sa/So, as well as the decreased downstream sphingolipids [61] [62] [63] . Disturbance in the sphingolipid metabolism is thought to be a major contributor to FB 1 toxicity; it can also interfere with folate transporters. In other words, another developmental toxicity of FB 1 is disruption of folate processing, due to its high-affinity for the folate transporter. This, in turn, can lead to an insufficient transfer of folates to a developing fetus, causing folate-deficient syndromes, during embryogenesis. This phenomenon is similar to that observed when pregnant animals are fed specific vitamin-deficient diets, such as folate-deficient diets. Therefore, FB 1 inhibition of ceramide biosynthesis can be plausibly linked to folate insufficiency and is closely associated with an increased risk of neural tube defects (NTDs) [64] [65] [66] [67] [68] [69] .
A possible etiological factor for embryo deaths and fetal malformations is maternal toxicity [70] [71] [72] . Collins et al. suggested that FB 1 was not teratogenic but that developmental variations induced by the mycotoxin were secondary to maternal toxicity. Overall, FB 1 exerts secondary to maternal toxicity, which includes growth impairment at high doses and fetal death in utero. In this study, signs of maternal toxicity (increased Sa/So ratios characteristic in maternal livers, kidneys, serum, and brains) were observed in kidneys and livers in all FB 1 -treated groups, but with no effect in fetuses [73] . Similarly, Reddy et al. found FB 1 -treated mice had increased Sa/So ratios in maternal organs, but not in fetal livers [74] . Therefore, the effects of FB 1 on fetuses, should be considered as secondary to maternal toxicity. 
Fumonisin B1 and Developmental Toxicity in Animals
As mentioned previously, mycotoxin FB1 might act as an embryonic or fetal cytotoxic agent (secondary to maternal toxicity), which results in growth retardation and developmental abnormalities, and indirectly induces NTDs when administered to pregnant animals. Previous studies about FB1 on developmental toxicity in rats, Syrian hamsters, mice, rabbits, humans, ruminants, and chickens are reviewed and summarized in Table 1 . 
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Mammalian Models

Rats
In vitro studies have shown that FB 1 retarded the growth of cultured rat embryos exposed to FB 1 concentrations ≥0.2 ppm, for 45 h, starting from E9.5. Phenotypic abnormalities significantly increased when FB 1 concentrations were greater than 0.5 ppm and reached 100% prevalence at 1.01-40.4 ppm [44] . Similarly, in rat embryos cultured with aminopentol (AP 1 ; 0, 2.17, 7.22, 21.7, 72.2, or 217 ppm), the hydrolysis product of FB 1, a significant increase was observed in the incidence of abnormal embryos (NTDs and other abnormalities) [76] . In both studies, the observed abnormalities were mainly in conjunction with the retardation of overall growth and development, suggesting that both AP 1 and FB 1 uniformly exert embryo-toxicity, in detriment to the entire embryo.
In contrast, results from an in vivo study found no overt adverse effects on the reproductive performance of either male or female rats, or their offspring when the rats were fed with FB 1 (1, 10, or 55 ppm), starting 9 and 2 weeks before mating. Briefly, litter weight gains in the 10 and 55 ppm FB 1 groups were slightly decreased; however, gross litter weight and physical development of offspring were not affected. Furthermore, altered sphingolipid ratios, specifically increased sphinganine to sphingosine ratios, were found in the livers of dams from the highest (55 ppm) FB 1 treatment group. However, sphingolipid ratios of abdominal sections, containing livers and kidneys, of fetuses showed no differences between the control and the highest dose litters [77] .
Hamsters
In Syrian hamsters, fetal body weight and crown-rump length appeared to decrease with the increased fetal deaths observed in dams, when the hamsters were given an oral administration of 6, 12, or 18 mg/kg-BW of FB 1 on E8 and E9, respectively [78] . A similar result was also reported in pregnant Syrian hamsters that were given 0, 8. 1 caused growth retardation and malformations of embryos, at all concentrations equal to or greater than 1.44 ppm. For instance, one of the NTD phenotypes (exencephaly) was observed at concentrations ≥1.44 ppm of FB 1 treatments, and its incidence increased from 10% at 1.44 ppm to 48% at 72.1 ppm (the highest concentration). At a 2 h exposure with 36 ppm FB 1 , the mouse embryo showed a retarded growth, with NTDs and facial hypoplasia observed in 67% and 83% of the tested embryos, respectively, [80] .
When inbred LM/Bc mice were given intraperitoneal dosages of FB 1 (0, 5, 10, 15, or 20 mg/kg) on E7.5 and E8.5, the incidence of fetuses showing exencephaly increased from 5% at 5 mg/kg to 79% at 20 mg/kg-BW of FB 1 treatments [43] . Similarly, Voss et al. found the incidence of NTD litters was 4/11 (36%), at 10 mg/kg-BW (maternal) of the mycotoxin given (intraperitoneal injection) to LM/Bc mice on E7 and E8 [64] .
Other experiments have indicated that CD1 mice are more resistant to NTDs induced by FB 1 than the LM/Bc mice. Tests on CD1 mice have shown that the fetal toxicity (fetal death and decreased fetal weight) was evident after exposure to FB 1 [74] . Voss et al. reported that developmental NTDs were less than 10% when mice were given 10 mg/kg-BW of FB 1 [81] ; however, FB 1 was found to be fetotoxic, at a maternal dose ≥45 mg/kg-BW, where 36% of mouse fetuses with NTDs were induced. Moreover, Liao et al. also showed that CD1 mice fed with 12.5 mg/kg had NTDs in 7.4% of the mouse fetuses examined [82] .
The comparison between the LM/Bc and CD1 females by Voss et al. [83] revealed a 10% incidence (1/10 fetuses) of exencephaly in the LM/Bc mouse fetuses, when female mice were fed with diets contaminated with 150 ppm FB 1 ; but no NTDs were found in the CD1 offspring, although the CD1 litters exhibited a higher fetal mortality. Conceivably, differential responses or sensitivity to FB 1 treatment could also exist even between these two mouse strains and not only among different animal species.
Rabbits
When given to New Zealand White rabbits by gavage (0, 0.1, 0.5, or 1.0 mg/kg-BW on E3 through E19 embryos), FB 1 caused maternal mortality and disrupted maternal sphingolipid metabolism at concentrations ≥0.5 mg/kg-BW. Apparently, FB 1 is fetotoxic at the two highest doses of 0.5 and 1.0 mg/kg-BW, as indicated by the reduced fetal body, kidney, and liver weights [84] . Exposure of male rabbits to FB 1 contaminated diets with up to 7.5 mg/kg FB 1 , depressed the testicular and epididymal sperm reserves, the sperm production, and potentially impaired reproduction of the buck, and in turn, induced embryo mortality, during later development [85] . Evidence of disrupted sphingolipid metabolism was not found in rabbit fetuses, suggesting that the effect of FB 1 on rabbits were also secondary to maternal toxicity.
Humans
Although FB 1 has been identified with significant health threats in livestock and many other animals, evidence for the same in humans is currently inconclusive. Some studies expressed concerns that exposure to FB 1 might contribute to serious adverse health outcomes, such as cancers and birth defects. One study on the incidence of NTDs among Mexican Americans at the Texas-Mexico border, suggested that FB 1 exposure in pregnant women might be a contributing factor to NTDs in babies. The NTD risk can increase in women consuming homemade tortillas, which contain approximately 0.234 ppm FB 1 , with daily exposure, approximately 0.1726 mg/day/kg-BW compared to the control group [91] . Callihan et al. suggested that the mechanism of FB 1 action has been confirmed in humans [86] . The alteration of sphingosine 1-phosphate (S1P) and its receptors, during the development of the nervous system, were observed. For instance, human neuroepithelial cells (hES-NEP) treated with various concentrations of (0.00072, 0.0072, 0.072, 0.72, 7.2, or 72 ppm) FB 1 , for 48 h, caused the inhibition of ceramide synthases and resulted in an accumulation of sphingoid-based dihydrosphingosine and the bioactive lysophosphosphingolipid dihydro-sphingosine 1-phosphate (dhS1P).
Cattle
The study of FB 1 on developmental toxicity in ruminants is relatively limited, compared to those in other animal species and humans. However, in vitro oocyte maturation (IVM) was compromised by FB 1 treatments, when bovine cumulus-oocyte complexes (COCs) were matured for 22 h, in a maturation medium containing 3.6, 7.2, 14.4, 21.6, or 36.0 ppm of FB 1 . Oocytes matured in the medium with 7.2 ppm FB 1 , decreased the proportion of the two-to four-celled embryos; oocytes matured with 14.4 ppm FB 1 had no changes in their cleavage rates but showed a reduced blastocyst rate on day 8, post-fertilization. When the highest concentration (36.0 ppm) of FB 1 was used, the most prominent effect on oocyte development was observed, in which the oocytes could not be normally fertilized or developed to the blastocyst stage [87] . In general, bovine oocytes matured in FB 1 -containing medium, also compromised the quality of developing embryos.
Avian Species
Javed et al. inoculated chicken eggs with (0, 0.72, 7.2, or 72 ppm) FB 1 or Fusarium proliferatum culture material extract (CME), to provide 14.4 ppm of FB 1 and 2.82 ppm FB 2 , on day 1 or day 10 of the 21-day incubation period. They found FB 1 increased embryo mortality from 50% to 100%, when inoculated with FB 1 , compared to a 100% mortality in the CME treatment. Early fetal abnormalities including hydrocephalus, enlarged beaks and elongated necks, were also observed in FB 1 -exposed embryos; pathologic changes were evident in livers, kidneys, heart, lungs, musculoskeletal system, intestines, testes, and brains, in these toxin-exposed embryos [88] . In agreement with Bacon et al., a significantly increased mortality of embryos was observed in the FB 1 -administered group [89] . Another study was performed by Henry et al. to confirm FB 1 toxicity, where broiler embryos were injected with 0 to 0.25 ppm FB 1 , followed by 72 h of incubation. By day 18, after FB 1 injection, the cumulative embryonic mortality (56%) drastically increased, compared to the control group (4%) [90] . It is, hence, clearly demonstrated that exposure to mycotoxin FB 1 adversely affected embryo survival and development in poultry. Unlike mammalian species, however, it remains unclear whether maternal exposure to mycotoxin FB 1 (acute and chronic) can cause accumulative effects that could directly carry over to the developing chick embryos. It would be of great interest to develop more in-depth studies to reveal this maternal-fetal portal of Fumonisin toxicity.
Concluding Remark
Mycotoxin FB 1 apparently acts directly or indirectly as an embryotoxic or fetotoxic teratogen to cause growth retardation, delayed or incomplete organogenesis, malformations, and ultimately fetal death, in several species, largely in a dose-dependent manner. Based on histopathological and sphingolipid profile assessments of the dams, fetotoxicity secondary to maternal toxic effects are also prominent. The mechanism of action for the toxicity of mycotoxin FB 1 is understood to be through the competitive inhibitors of ceramide synthase in the de novo sphingolipid biosynthetic pathway. However, there is still no adequate evidence to implicate the initial alterations caused by FB 1 , particularly during early embryogenesis; similar studies in domestic species are also largely unavailable. Nevertheless, comparative studies between sensitive and non-sensitive animals might be necessary to determine which animal model is most relevant to humans. It would be useful to further investigate the specific toxicity and derive more conclusive mechanisms in Homo sapiens. Furthermore, due to the frequent higher level of FB 1 contaminants, compared to the safety allowance recommended by the European Union (Commission of European Communities) and the USFDA Center for Food Safety and Nutrition, it is essential to develop an effective strategy to minimize risks of FB 1 exposure for both animal species and human beings. Funding: This research received no external funding.
